The U.S. Food and Drug Administration late final yr received extra leverage over pharmaceutical firms that obtained accelerated approvals for his or her medication. How will the company use its new powers?
Copyright © 2023 NPR. All rights reserved. Visit our web site phrases of use and permissions pages at www.npr.org for additional data.
NPR transcripts are created on a rush deadline by an NPR contractor. This textual content might not be in its remaining kind and could also be up to date or revised sooner or later. Accuracy and availability might range. The authoritative file of NPR’s programming is the audio file.